31
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Cirrhotic Patients With or Without Hepatocellular Carcinoma Harbour AFP-Specific T-Lymphocytes That Can Be Activated in vitro by Human Alpha-Fetoprotein

Pages 949-955 | Published online: 08 Jul 2009

  • Dürr R, Caselmann WH. Carcinogenesi s of primary liver malignancies. Langenbecks Arch Surg 2000;385:154-61.
  • Caselmann WH, Blum HE, Fleig WE, Huppert PE, Ramadori G, Schirmacher P, et al. (Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases). Z Gastroenterol 1999;37:353-65.
  • Deutsch HF. Chemistry and biology of alpha-fetoprotein. Adv Cancer Res 1991;56:253 -312.
  • Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, et al. Alpha-fetoprotein-speci fie genetic immunotherapy for hepatocellular carcinoma. Cancer Res 1999:59:3064-7.
  • Hanke P, Serwe M, Dombrowski F, Reimann J, Sauerbruch T, Caselmann WH. DNA vaccination with alpha-fetoprotein encoding plasmid DNA prevents growth of subcutaneous AFPexpressin g tumors and does not interfere with liver regeneration in mice. Cancer Gene Ther 2002;9:345-55.
  • Grimm CF, Ortmann D, Mohr L, Michalak S, Krohne TU, Meckel S, et al. Mouse alpha-fetoprotein-speci fie DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice. Gastroenterology 2000;119:1104-12.
  • Bei R, Budillon A, Reale MG, Capuano G, Pomponi D, Budillon G, et al. Cryptic epitopes on alpha-fetoprotein induce spontaneous immune responses in hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis patients. Cancer Res 1999;59: 5471-4.
  • Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, et al. Generation of human T-cell responses to an HLA-A2.1 restricted peptide epitope derived from alpha-fetoprotein. Cancer Res 1999:59:3134-42.
  • Brosterhus H, Brings S, Leyendeckers H, Manz RA, Miltenyi S, Radbruch A, et al. Enrichment and detection of live antigenspecific CD4(+) and CD8(+) T cells based on cytokine secretion. Eur J Immunol 1999;29:4053-9.
  • Salmon M, Kitas GD, Bacon PA. Production of lymphokine mRNA by CD45R+ and CD45R-helper T cells from human peripheral blood and by human CD4+ T cell clones. J Immunol 1989:143:907-12.
  • Hamann D, Baars PA, Rep MH, Hooibrink B, Keikhof-Garde SR, Klein MR, et al. Phenotypic and functional separation of memory and effector human CDS+ T cells. J Exp Med 1997; 186:1407-18.
  • Collins DP. Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model systems. J Immunol Methods 2000:243:125-45.
  • Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Semin Nephrol 1996;16:183-91.
  • Saibara T, Onishi S, Sakaeda H, Yamamoto Y. Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma. Hepatology 1989:9:471-6.
  • Chu MH, Chien SC, Hu CP, Wang CY, Lee SD, Tsai YT, et al. Natural and activated cytotoxic lymphocytes reactivity to human hepatocellular carcinoma cell lines in hepatocellular carcinoma patients. Liver 1988:8:198-207.
  • Kakumu S, Ito S, Ishikawa T, Mfta Y, Tagaya T, Pukuzawa Y, Yoshioka K. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 2000;15:431 -6.
  • Ninomiya T, Akbar SM, Masumoto T, Horiike N, Onji M. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 1999;31:323-31.
  • Lee CS. Lymphocytes and their subsets in the peripheral blood of hepatocellular carcinoma patients. J Formos Med Assoc 1991; 90:626-30.
  • Chavan SS, Chiplunkar SV. Immunophenotypes and cytotoxic functions of lymphocytes in patients with hepatocellular carcinoma. Tumori 1997;83:762-7.
  • Limmer A, Sacher T, Alferink J, Kretschmar M, Schonrich G, Nichterlein T, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Bur J Immunol 1998;28:2395-406.
  • Yamashha T, Nakane A, Watanabe T, Miyoshi I, Kasai N. Evidence that alpha-fetoprotein suppresses the immunological function in transgenic mice. Biochem Biophys Res Commun 1994:201:1154-9.
  • Ando K, Guidotti LG, Cemy A, Ishikawa T, Chisari FV. CTL access to tissue antigen is restricted in vivo. J Immunol 1994; 153:482-8.
  • Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000;174:21 -34.
  • Limmer A, OhI J, Kurts C, Ljunggren HG, Reiss Y, Groettrup M, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific Tcell tolerance. Nat Med 2000;6:1348-54.
  • Thomson AW, Lu L. Are dendritic cells the key to liver transplant tolerance? Immunol Today 199920:27-32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.